Skip to main content
SpringerLink
Log in

Simultaneous subcutaneous implantable cardioverter-defibrillator and leadless pacemaker implantation for patients at high risk of infection: a retrospective case series report

  • Review
  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Background

The subcutaneous implantable cardioverter defibrillator (S-ICD) and leadless pacemaker (LP) are alternative options for patients at high risk of infection requiring ICD and pacing therapy. In this analysis, we described the simultaneous implantation of S-ICD and LP in patients with high infectious risk.

Methods

The study cohort comprised patients referred to our institution for ICD implantation due to high-risk factors of infection.

Results

Between 2018 and 2022, 13 patients were referred, including 11 with infected ICD and 2 for first ICD implantation in the presence of high-risk factors. In cases of infected ICD, successful extraction was performed using a mechanical dilatation technique. Reimplantation was delayed until resolution of infection with antibiotic therapy. The devices were implanted during a single procedure, with S-ICD implantation following LP placement for verification of sensing adequacy through surface ECG screening. Suitable vectors for sensing during inhibited and ventricular pacing were identified in all patients. Defibrillation testing was effective, and no issues with double counting or undersensing were observed. The postoperative period was uneventful, and during a median follow-up of 35 months, no complications or infections were reported. The median ventricular pacing percentage was 5%, and a single inappropriate shock episode due to myopotential interference was reported and resolved by reprogramming the sensing vector.

Conclusion

Simultaneous implantation of S-ICD and LP is feasible and safe in patients at high risk of infection requiring both ICD and pacing therapy. This combined approach provides an effective solution for these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, Charron P, Corrado D, Dagres N, de Chillou C, Eckardt L, Friede T, Haugaa KH, Hocini M, Lambiase PD, Marijon E, Merino JL, Peichl P, Priori SG, et al. ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;2022(43):3997–4126.

    Article  Google Scholar 

  2. TA MD, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, JGF C, AJS C, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;2021(42):3599–726.

    Google Scholar 

  3. Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P, Simpson CS, Khaykin Y, Cameron D, Janmohamed A, Yee R, Austin PC, Chen Z, Hardy J, Tu JV. Investigators of the Ontario ICD Database. Evaluation of early complications related to de novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol. 2010;55:774–82.

    Article  PubMed  Google Scholar 

  4. Ranasinghe I, Parzynski CS, Freeman JV, Dreyer RP, Ross JS, Akar JG, Krumholz HM, Curtis JP. Long-term risk for device-related complications and reoperations after implantable cardioverter-defibrillator implantation: an observational cohort study. Ann Intern Med. 2016;165:20–9.

    Article  PubMed  Google Scholar 

  5. Bongiorni MG, Kennergren C, Butter C, Deharo JC, Kutarski A, Rinaldi CA, Romano SL, Maggioni AP, Andarala M, Auricchio A, Kuck KH, Blomström-Lundqvist C, ELECTRa Investigators. The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) registry of transvenous lead extraction outcomes. Eur Heart J. 2017;38:2995–3005.

    Article  PubMed  Google Scholar 

  6. Kirkfeldt RE, Johansen JB, Nohr EA, Jørgensen OD, Nielsen JC. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J. 2014;35:1186–94.

    Article  PubMed  Google Scholar 

  7. Tarakji KG, Wazni OM, Harb S, Hsu A, Saliba W, Wilkoff BL. Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival. Europace. 2014;16:1490–5.

    Article  PubMed  Google Scholar 

  8. Kusumoto FM, Schoenfeld MH, Wilkoff BL, Berul CI, Birgersdotter-Green UM, Carrillo R, Cha YM, Clancy J, Deharo JC, Ellenbogen KA, Exner D, Hussein AA, Kennergren C, Krahn A, Lee R, Love CJ, Madden RA, Mazzetti HA, Moore JC, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14:e503–51.

    Article  PubMed  Google Scholar 

  9. Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, Rashtian M, Kremers M, Crozier I, Lee KL, Smith W, Burke MC. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation. 2013;128:944–53.

    Article  PubMed  Google Scholar 

  10. Lambiase PD, Theuns DA, Murgatroyd F, Barr C, Eckardt L, Neuzil P, Scholten M, Hood M, Kuschyk J, Brisben AJ, Carter N, Stivland TM, Knops R, Boersma LVA. Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study. Eur Heart J. 2022;43:2037–50.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72:e91–e220.

    Article  PubMed  Google Scholar 

  12. Viani S, Migliore F, Tola G, Pisanò ECL, Russo AD, Luzzi G, Sartori P, Piro A, Rordorf R, Forleo GB, Rago A, Segreti L, Bertaglia E, Biffi M, Lovecchio M, Valsecchi S, Diemberger I, Bongiorni MG. Use and outcomes of subcutaneous implantable cardioverter-defibrillator (ICD) after transvenous ICD extraction: an analysis of current clinical practice and a comparison with transvenous ICD reimplantation. Heart Rhythm. 2019;16:564–71.

    Article  PubMed  Google Scholar 

  13. Giacomin E, Falzone PV, Dall'Aglio PB, Pittorru R, De Lazzari M, Vianello R, Bertaglia E, Tarzia V, Iliceto S, Gerosa G, Migliore F. Subcutaneous implantable cardioverter defibrillator after transvenous lead extraction: safety, efficacy and outcome. J Interv Card Electrophysiol. 2022; https://doi.org/10.1007/s10840-022-01293-y.

  14. Huang J, Patton KK, Prutkin JM. Concomitant use of the subcutaneous implantable cardioverter defibrillator and a permanent pacemaker. Pacing Clin Electrophysiol. 2016;39:1240–5.

    Article  PubMed  Google Scholar 

  15. Porterfield C, DiMarco JP, Mason PK. Effectiveness of implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with complete heart block and a pacemaker. Am J Cardiol. 2015;115:276–8.

    Article  Google Scholar 

  16. Sarubbi B, Colonna D, Correra A, Romeo E, D'Alto M, Palladino MT, Virno S, D'Onofrio A, Russo MG. Subcutaneous implantable cardioverter defibrillator in children and adolescents: results from the S-ICD “Monaldi care” registry. J Interv Card Electrophysiol. 2022;63:283–93.

    Article  PubMed  Google Scholar 

  17. Kajiyama T, Kondo Y, Nakano M, Chiba T, Kobayashi Y. Concomitant use and interaction of a subcutaneous implantable defibrillator and epicardial pacemaker. J Arrhythm. 2021;38:155–6.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Rutzen-Lopez H, Silva J, Helm RH. Leadless cardiac devices-pacemakers and implantable cardioverter-defibrillators. Curr Treat Options Cardiovasc Med. 2016;18:49.

    Article  PubMed  Google Scholar 

  19. Ahmed FZ, Cunnington C, Motwani M, Zaidi AM. Totally leadless dual-device implantation for combined spontaneous ventricular tachycardia defibrillation and pacemaker function: a first report. Can J Cardiol. 2017;33:1066.e5–7.

    Article  PubMed  Google Scholar 

  20. Montgomery JA, Orton JM, Ellis CR. Feasibility of defibrillation and pacing without transvenous leads in a combined MICRA and S-ICD system following lead extraction. J Cardiovasc Electrophysiol. 2017;28:233–4.

    Article  PubMed  Google Scholar 

  21. Ng JB, Chua K, Teo WS. Simultaneous leadless pacemaker and subcutaneous implantable cardioverter-defibrillator implantation-when vascular options have run out. J Arrhythm. 2018;35:136–8.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Ljungström E, Brandt J, Mörtsell D, Borgquist R, Wang L. Combination of a leadless pacemaker and subcutaneous defibrillator with nine effective shock treatments during follow-up of 18 months. J Electrocardiol. 2019;56:1–3.

    Article  PubMed  Google Scholar 

  23. Calvagna GM, Patanè S, Romeo P. Transcatheter pacing system and leadless defibrillator: a solution in a complex case. A case report of a patient with previous device-related infection and persistent left-sided superior vena cava. HeartRhythm Case Rep. 2020;7:12–5.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Fernández-Palacios G, García-Morán E, Sandín-Fuentes M, García-Granja PE, Rubio J, San Román AJ. The utility of a combined synchronous atrioventricular leadless pacemaker and subcutaneous implantable cardiac defibrillator system in bilateral upper limb venous occlusion. Europace. 2021;23:814.

    Article  PubMed  Google Scholar 

  25. Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, Barrabés JA, Boriani G, Braunschweig F, Brignole M, Burri H, Coats AJS, Deharo JC, Delgado V, Diller GP, Israel CW, Keren A, Knops RE, Kotecha D, et al. 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Europace. 2022;24:71–164.

    Article  PubMed  Google Scholar 

  26. Francia P, Ziacchi M, De Filippo P, Viani S, D'Onofrio A, Russo V, Adduci C, Biffi M, Ferrari P, Bianchi V, Ammendola E, Palano F, Frisoni J, Valsecchi S, Lovecchio M, Bongiorni MG. Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool. J Interv Card Electrophysiol. 2018;52:61–7.

    Article  PubMed  Google Scholar 

  27. Calvagna GM, Evola R, Scardace G, Valsecchi S. Single-operator experience with a mechanical approach for removal of pacing and implantable defibrillator leads. Europace. 2009;11:1505–9.

    Article  PubMed  Google Scholar 

  28. Migliore F, Pittorru R, Giacomin E, Dall'Aglio PB, Falzone PV, Bertaglia E, Iliceto S, Gregori D, De Lazzari M, Corrado D. Intermuscular two-incision technique for implantation of the subcutaneous implantable cardioverter defibrillator: a 3-year follow-up. J Interv Card Electrophysiol. 2023; https://doi.org/10.1007/s10840-023-01478-z.

  29. Knops RE, Olde Nordkamp LR, de Groot JR, Wilde AA. Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2013;10:1240–3.

    Article  PubMed  Google Scholar 

  30. Blomström-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, Poole J, Boriani G, Costa R, Deharo JC, Epstein LM, Saghy L, Snygg-Martin U, Starck C, Tascini C, Strathmore N. ESC Scientific Document Group. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Europace. 2020;22:515–49.

    Article  PubMed  Google Scholar 

  31. Rizwan Sohail M, Henrikson CA, Jo Braid-Forbes M, Forbes KF, Lerner DJ. Increased long-term mortality in patients with cardiovascular implantable electronic device infections. Pacing Clin Electrophysiol. 2015;38:231–9.

    Article  Google Scholar 

  32. Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med. 2011;171:1821–8.

    Article  PubMed  Google Scholar 

  33. Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace. 2015;17:767–77.

    Article  Google Scholar 

  34. Knops RE, Pepplinkhuizen S, Delnoy PPHM, Boersma LVA, Kuschyk J, El-Chami MF, Bonnemeier H, Behr ER, Brouwer TF, Kaab S, Mittal S, Quast ABE, van der Stuijt W, Smeding L, de Veld JA, Tijssen JGP, Bijsterveld NR, Richter S, Brouwer MA, et al. Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial. Eur Heart J. 2022;43:4872–83.

    Article  PubMed Central  Google Scholar 

  35. Palmisano P, Ziacchi M, Ammendola E, D'Onofrio A, Dell'Era G, Laffi M, Biffi M, Nigro G, Bianchi W, Prenna E, Angeletti A, Guido A, Stronati G, Gaggioli G, Dello Russo A, Accogli M, Guerra F. Italian Association of Arrhythmology and Cardiac Pacing (AIAC). Rate and impact on patient outcome and healthcare utilization of complications requiring surgical revision: subcutaneous versus transvenous implantable defibrillator therapy. J Cardiovasc Electrophysiol. 2021;32:1712–23.

    Article  Google Scholar 

  36. Gold MR, Aasbo JD, Weiss R, Burke MC, Gleva MJ, Knight BP, Miller MA, Schuger CD, Carter N, Leigh J, Brisben AJ, El-Chami MF. Infection in patients with subcutaneous implantable cardioverter-defibrillator: results of the S-ICD Post Approval Study. Heart Rhythm. 2022;19:1993–2001.

    Article  PubMed  Google Scholar 

  37. El-Chami MF, Knight BP, Liu Y, Brisben AJ, Sohail MR, Griffiths RI. Temporal trends of device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patients with underlying kidney disease. Heart Rhythm. 2022;19:1689–95.

    Article  PubMed  Google Scholar 

  38. De Filippo P, Migliore F, Palmisano P, Nigro G, Ziacchi M, Rordorf R, Pieragnoli P, Di Grazia A, Ottaviano L, Francia P, Pisanò E, Tola G, Giammaria M, D’Onofrio A, Botto GL, Zucchelli G, Ferrari P, Lovecchio M, Valsecchi S, Viani S. Procedure, management and outcome of subcutaneous implantable cardioverter-defibrillator extraction in clinical practice. Europace. 2023; In press

  39. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Stoner S, Baddour LM. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49:1851–9.

    Article  PubMed  Google Scholar 

  40. Beurskens NEG, Tjong FVY, Dasselaar KJ, Kuijt WJ, Wilde AAM, Knops RE. Leadless pacemaker implantation after explantation of infected conventional pacemaker systems: a viable solution? Heart Rhythm. 2019;16:66–71.

    Article  PubMed  Google Scholar 

  41. El-Chami MF, Johansen JB, Zaidi A, Faerestrand S, Reynolds D, Garcia-Seara J, Mansourati J, Pasquie JL, McElderry HT, Roberts PR, Soejima K, Stromberg K, Piccini JP. Leadless pacemaker implant in patients with pre-existing infections: results from the Micra postapproval registry. J Cardiovasc Electrophysiol. 2019;30:569–74.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Steinwender C, Khelae SK, Garweg C, Chan JYS, Ritter P, Johansen JB, Sagi V, Epstein LM, Piccini JP, Pascual M, Mont L, Sheldon T, Splett V, Stromberg K, Wood N, Chinitz L. Atrioventricular synchronous pacing using a leadless ventricular pacemaker: results from the MARVEL 2 study. JACC Clin Electrophysiol. 2020;6:94–106.

    Article  PubMed  Google Scholar 

  43. Knops RE, Reddy VY, Ip JE, Doshi R, Exner DV, Defaye P, Canby R, Bongiorni MG, Shoda M, Hindricks G, Neužil P, Rashtian M, Breeman KTN, Nevo JR, Ganz L, Hubbard C, Cantillon DJ. Aveir DR i2i Study Investigators. A dual-chamber leadless pacemaker. N Engl J Med. 2023; https://doi.org/10.1056/NEJMoa2300080.

  44. Lloyd MS, Brisben AJ, Reddy VY, Blomström-Lundqvist C, Boersma LVA, Bongiorni MG, Burke MC, Cantillon DJ, Doshi R, Friedman PA, Gras D, Kutalek SP, Neuzil P, Roberts PR, Wright DJ, Appl U, West J, Carter N, Stein KM, et al. Design and rationale of the modular ATP global clinical trial: a novel intercommunicative leadless pacing system and the subcutaneous implantable cardioverter defibrillator. Heart Rhythm O2. 2023; https://doi.org/10.1016/j.hroo.2023.05.004.

  45. Breeman KTN, Swackhamer B, Brisben AJ, Quast ABE, Carter N, Shuros A, Soltis B, Koop BE, Burke MC, Wilde AAM, Tjong FVY, Knops RE. Long-term performance of a novel communicating antitachycardia pacing-enabled leadless pacemaker and subcutaneous implantable cardioverter-defibrillator system: a comprehensive preclinical study. Heart Rhythm. 2022;19:837–46.

    Article  PubMed  Google Scholar 

  46. Friedman P, Murgatroyd F, Boersma LVA, Manlucu J, O'Donnell D, Knight BP, Clémenty N, Leclercq C, Amin A, Merkely BP, Birgersdotter-Green UM, Chan JYS, Biffi M, Knops RE, Engel G, Muñoz Carvajal I, Epstein LM, Sagi V, Johansen JB, et al. Extravascular ICD Pivotal Study Investigators. Efficacy and safety of an extravascular implantable cardioverter-defibrillator. N Engl J Med. 2022;387:1292–302.

    Article  PubMed  Google Scholar 

  47. Okamura H, McLeod CJ, DeSimone CV, Webster TL, Bonnichsen CR, Grogan M, Phillips SD, Connolly HM, Ammash NM, Warnes CA, Friedman PA. Right parasternal lead placement increases eligibility for subcutaneous implantable cardioverter defibrillator therapy in adults with congenital heart disease. Circ J. 2016;80:1328–35.

    Article  PubMed  Google Scholar 

  48. ElRefai M, Abouelasaad M, Menexi C, Morgan J, Roberts PR. Impact of right ventricular pacing site on the subcutaneous ICD sensing-a step towards personalised device therapy? J Interv Card Electrophysiol. 2022; https://doi.org/10.1007/s10840-022-01218-9.

  49. Willcox ME, Prutkin JM, Bardy GH. Recent developments in the subcutaneous ICD. Trends Cardiovasc Med. 2016;26:526–35.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, ARNAS Garibaldi Centro, Catania, Italy

    Giuseppe M. Calvagna

  2. Boston Scientific, Milan, Italy

    Sergio Valsecchi

Authors
  1. Giuseppe M. Calvagna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sergio Valsecchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giuseppe M. Calvagna.

Ethics declarations

Competing interests

S. Valsecchi is an employee of Boston Scientific. The other author reports no conflicts.

Funding

This was an independent study. No external funding was received for this project.

Data availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Calvagna, G.M., Valsecchi, S. Simultaneous subcutaneous implantable cardioverter-defibrillator and leadless pacemaker implantation for patients at high risk of infection: a retrospective case series report. J Interv Card Electrophysiol (2023). https://doi.org/10.1007/s10840-023-01684-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10840-023-01684-9

Keywords

Search

Navigation